The DCGI has approved CORBEVAX, a product produced by Biological E Limited, for Emergency Use Authorization (EUA) in the 12-18-year-old age group
CORBEVAX, Biological E Limited’s first indigenously designed Receptor Binding Domain (RBD) protein subunit vaccine for COVID-19, has acquired Emergency Use Authorization from the Drug Controller General of India (DCGI) for the 12-18 year age range. … Read more